vs

Side-by-side financial comparison of Shimmick Corp (SHIM) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $141.9M, roughly 1.1× Shimmick Corp). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -3.1%, a 74.3% gap on every dollar of revenue. Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-28.7M).

Shimmick Corp is a U.S.-based heavy civil construction firm specializing in building and upgrading critical public infrastructure, including water facilities, transportation systems, dams, and environmental remediation projects. It primarily serves federal, state, and local government clients across North America, delivering complex large-scale construction solutions for public sector segments.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

SHIM vs STOK — Head-to-Head

Bigger by revenue
STOK
STOK
1.1× larger
STOK
$158.6M
$141.9M
SHIM
Higher net margin
STOK
STOK
74.3% more per $
STOK
71.2%
-3.1%
SHIM
More free cash flow
STOK
STOK
$160.4M more FCF
STOK
$131.7M
$-28.7M
SHIM

Income Statement — Q3 FY2025 vs Q1 FY2025

Metric
SHIM
SHIM
STOK
STOK
Revenue
$141.9M
$158.6M
Net Profit
$-4.4M
$112.9M
Gross Margin
7.6%
Operating Margin
-2.2%
70.2%
Net Margin
-3.1%
71.2%
Revenue YoY
3661.1%
Net Profit YoY
528.0%
EPS (diluted)
$-0.12
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SHIM
SHIM
STOK
STOK
Q4 25
$141.9M
Q3 25
$128.4M
Q2 25
$122.1M
Q1 25
$103.6M
$158.6M
Q4 24
$22.6M
Q3 24
$166.0M
Q2 24
$90.6M
Q1 24
$120.0M
Net Profit
SHIM
SHIM
STOK
STOK
Q4 25
$-4.4M
Q3 25
$-8.5M
Q2 25
$-9.8M
Q1 25
$-38.5M
$112.9M
Q4 24
$-10.5M
Q3 24
$-1.6M
Q2 24
$-51.4M
Q1 24
$-33.3M
Gross Margin
SHIM
SHIM
STOK
STOK
Q4 25
7.6%
Q3 25
6.3%
Q2 25
3.8%
Q1 25
-20.1%
Q4 24
Q3 24
7.3%
Q2 24
-34.4%
Q1 24
-13.2%
Operating Margin
SHIM
SHIM
STOK
STOK
Q4 25
-2.2%
Q3 25
-5.5%
Q2 25
-7.3%
Q1 25
-39.3%
70.2%
Q4 24
-60.4%
Q3 24
0.7%
Q2 24
-53.0%
Q1 24
-26.5%
Net Margin
SHIM
SHIM
STOK
STOK
Q4 25
-3.1%
Q3 25
-6.6%
Q2 25
-8.0%
Q1 25
-37.1%
71.2%
Q4 24
-46.4%
Q3 24
-0.9%
Q2 24
-56.7%
Q1 24
-27.8%
EPS (diluted)
SHIM
SHIM
STOK
STOK
Q4 25
$-0.12
Q3 25
$-0.25
Q2 25
$-0.28
Q1 25
$-0.92
$1.90
Q4 24
$-0.15
Q3 24
$-0.05
Q2 24
$-1.83
Q1 24
$-1.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SHIM
SHIM
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$17.6M
$274.8M
Total DebtLower is stronger
$57.5M
Stockholders' EquityBook value
$-52.7M
$350.1M
Total Assets
$218.5M
$406.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SHIM
SHIM
STOK
STOK
Q4 25
$17.6M
Q3 25
$21.4M
Q2 25
$16.3M
Q1 25
$33.7M
$274.8M
Q4 24
$128.0M
Q3 24
$26.0M
Q2 24
$22.4M
Q1 24
$27.3M
Total Debt
SHIM
SHIM
STOK
STOK
Q4 25
$57.5M
Q3 25
$36.4M
Q2 25
$31.4M
Q1 25
$9.5M
Q4 24
Q3 24
$39.9M
Q2 24
Q1 24
$31.5M
Stockholders' Equity
SHIM
SHIM
STOK
STOK
Q4 25
$-52.7M
Q3 25
$-49.5M
Q2 25
$-42.6M
Q1 25
$-34.7M
$350.1M
Q4 24
$229.0M
Q3 24
$973.0K
Q2 24
$436.0K
Q1 24
$38.1M
Total Assets
SHIM
SHIM
STOK
STOK
Q4 25
$218.5M
Q3 25
$203.0M
Q2 25
$227.7M
Q1 25
$233.9M
$406.9M
Q4 24
$271.6M
Q3 24
$346.7M
Q2 24
$344.5M
Q1 24
$378.0M
Debt / Equity
SHIM
SHIM
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
41.01×
Q2 24
Q1 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SHIM
SHIM
STOK
STOK
Operating Cash FlowLast quarter
$-23.7M
$131.8M
Free Cash FlowOCF − Capex
$-28.7M
$131.7M
FCF MarginFCF / Revenue
-20.2%
83.0%
Capex IntensityCapex / Revenue
3.5%
0.1%
Cash ConversionOCF / Net Profit
1.17×
TTM Free Cash FlowTrailing 4 quarters
$-27.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SHIM
SHIM
STOK
STOK
Q4 25
$-23.7M
Q3 25
$-3.8M
Q2 25
$-38.2M
Q1 25
$44.9M
$131.8M
Q4 24
$-23.2M
Q3 24
$12.7M
Q2 24
$-43.9M
Q1 24
$-35.0M
Free Cash Flow
SHIM
SHIM
STOK
STOK
Q4 25
$-28.7M
Q3 25
$-4.2M
Q2 25
$-38.7M
Q1 25
$44.4M
$131.7M
Q4 24
$-23.2M
Q3 24
$10.3M
Q2 24
$-46.8M
Q1 24
$-39.6M
FCF Margin
SHIM
SHIM
STOK
STOK
Q4 25
-20.2%
Q3 25
-3.2%
Q2 25
-31.7%
Q1 25
42.9%
83.0%
Q4 24
-102.7%
Q3 24
6.2%
Q2 24
-51.7%
Q1 24
-33.0%
Capex Intensity
SHIM
SHIM
STOK
STOK
Q4 25
3.5%
Q3 25
0.3%
Q2 25
0.4%
Q1 25
0.5%
0.1%
Q4 24
0.2%
Q3 24
1.4%
Q2 24
3.3%
Q1 24
3.8%
Cash Conversion
SHIM
SHIM
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
1.17×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SHIM
SHIM

Shimmick Projects$106.8M75%
Non Core Projects$35.1M25%

STOK
STOK

Segment breakdown not available.

Related Comparisons